-
3441
Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal can...
Published 2024-02-01“…Secondary endpoints include overall safety, efficacy, survival, quality of life, and pharmacokinetic investigations.Ethics and disseminationThe CD276xCD3 study was approved by the Ethics Committee of the Medical Faculty of the Heinrich Heine University Düsseldorf and the Paul-Ehrlich-Institut (P00702). …”
Get full text
Article -
3442
-
3443
-
3444
-
3445
-
3446
Towards a European health research and innovation cloud (HRIC)
Published 2020-02-01Get full text
Article -
3447
-
3448
-
3449
-
3450
-
3451
-
3452
-
3453
-
3454
-
3455
-
3456
-
3457
L-DOPA increases slow-wave sleep duration and selectively modulates memory persistence in older adults
Published 2023-04-01Get full text
Article -
3458
-
3459
Acridones as promising drug candidates against Oropouche virus
Published 2024-01-01Get full text
Article -
3460
The Global Brain Health Survey: Development of a Multi-Language Survey of Public Views on Brain Health
Published 2020-08-01Get full text
Article